David S. Finbloom
Food and Drug Administration
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by David S. Finbloom.
Molecular and Cellular Biology | 1997
Louis F. Stancato; Minoru Sakatsume; Michael David; Paul Dent; Fan Dong; Emanuel F. Petricoin; John J. Krolewski; Olli Silvennoinen; Pipsa Saharinen; Jacalyn H. Pierce; Christopher J. Marshall; Thomas W. Sturgill; David S. Finbloom; Andrew C. Larner
Activation of early response genes by interferons (IFNs) and other cytokines requires tyrosine phosphorylation of a family of transcription factors termed signal transducers and activators of transcription (Stats). The Janus family of tyrosine kinases (Jak1, Jak2, Jak3, and Tyk2) is required for cytokine-induced tyrosine phosphorylation and dimerization of the Stat proteins. In order for IFNs to stimulate maximal expression of Stat1alpha-regulated genes, phosphorylation of a serine residue in the carboxy terminus by mitogen-activated protein kinase (MAPK) is also required. In HeLa cells, both IFN-beta and oncostatin M (OSM) stimulated MAPK and Raf-1 enzyme activity, in addition to Stat1 and Stat3 tyrosine phosphorylation. OSM stimulation of Raf-1 correlated with GTP loading of Ras, whereas IFN-beta activation of Raf-1 was Ras independent. IFN-beta- and OSM-induced Raf-1 activity could be coimmunoprecipitated with either Jak1 or Tyk2. Furthermore, HeLa cells lacking Jak1 displayed no activation of STAT1alpha, STAT3, and Raf-1 by IFN-beta or OSM and also demonstrated no increase in the relative level of GTP-bound p21ras in response to OSM. The requirement for Jak1 for IFN-beta- and OSM-induced activation of Raf-1 was also seen in Jak1-deficient U4A fibrosarcoma cells. Interestingly, basal MAPK, but not Raf-1, activity was constitutively enhanced in Jak1-deficient HeLa cells. Transient expression of Jak1 in both Jak-deficient HeLa cells and U4A cells reconstituted the ability of IFN-beta and OSM to activate Raf-1 and decreased the basal activity of MAPK, while expression of a kinase-inactive form of the protein showed no effect. Moreover, U4A cells selected for stable expression of Jak1, or COS cells transiently expressing Jak1 or Tyk2 but not Jak3, exhibited enhanced Raf-1 activity. Therefore, it appears that Jak1 is required for Raf-1 activation by both IFN-beta and OSM. These results provide evidence for a link between the Jaks and the Raf/MAPK signaling pathways.
Molecular and Cellular Biology | 1993
K.-I. Igarashi; M. David; Andrew C. Larner; David S. Finbloom
Gamma interferon (IFN-gamma) activates the formation of a DNA-binding protein complex (FcRF gamma) that recognizes the gamma response region (GRR) of the promoter for the human high-affinity Fc gamma receptor. In a membrane-enriched fraction prepared from human peripheral blood monocytes, IFN-gamma activation of FcRF gamma occurred within 1 min and was ATP dependent. Activation of FcRF gamma required a tyrosine kinase activity, and recognition of the GRR sequence by FcRF gamma could be abrogated by treatment with a tyrosine-specific protein phosphatase. Treatment of cells with vanadate alone resulted in the formation of FcRF gamma without the need for IFN-gamma. UV cross-linking and antibody competition experiments demonstrated that the FcRF gamma complex was composed of at least two components: the 91-kDa protein of the IFN-alpha-induced transcription complex ISGF3 and a 43-kDa component that bound directly to the GRR. Therefore, specificity for IFN-induced transcriptional activation of early response genes requires at least two events: (i) ligand-induced activation of membrane-associated protein by tyrosine phosphorylation and (ii) formation of a complex composed of an activated membrane protein(s) and a sequence-specific DNA-binding component.
Blood | 1999
Satoshi Ito; Parswa Ansari; Minoru Sakatsume; Harold Dickensheets; Nancy Vázquez; Raymond P. Donnelly; Andrew C. Larner; David S. Finbloom
Blood | 1997
Gerald M. Feldman; Louis A. Rosenthal; Xiuwen Liu; Mark P. Hayes; Anthony Wynshaw-Boris; Warren J. Leonard; Lothar Hennighausen; David S. Finbloom
Journal of Biological Chemistry | 1994
Gerald M. Feldman; Emanuel F. Petricoin; Michael David; Andrew C. Larner; David S. Finbloom
Journal of Biological Chemistry | 1995
Sharon M. Sweitzer; Soledad Calvo; Matthias H. Kraus; David S. Finbloom; Andrew C. Larner
Blood | 1991
Gerald M. Feldman; Stefan Ruhl; Matthias Bickel; David S. Finbloom; Pluznik Dh
Biochemical Society Transactions | 1990
David S. Finbloom
Archive | 2013
Lothar Hennighausen; David S. Finbloom; Gerald M. Feldman; Louis A. Rosenthal; Xiuwen Liu; Mark P. Hayes; Anthony Wynshaw-Boris; J Warren
Archive | 2013
Andrew C. Larner; David S. Finbloom; Satoshi Ito; Minoru Sakatsume; Harold Dickensheets; Nancy Vázquez